STERIS insider files Form 144 to sell shares
STERIS plc insider files Form 144 to sell shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
STERIS plc insider files Form 144 to sell shares. Director or reporting person Daniel A. Carestio reported transactions tied to equity compensation. The filing lists 1,374 shares associated with a restricted stock lapse on 06/02/2026 and shows 3,054 shares sold during the prior three months on 06/04/2026 for $655,511.00.
Insights
Routine disclosure of insider sales tied to compensation and recent dispositions.
The excerpt lists a restricted stock lapse dated 06/02/2026 for 1,374 shares, described as Equity Compensation. It also records 3,054 shares sold on 06/04/2026 with a reported value of $655,511.00.
These entries are administrative disclosures of sales and vesting; cash‑flow treatment and broker routing are not specified in the provided excerpt. Subsequent filings or broker confirmations would provide execution details.
Key Figures
Key Terms
Restricted Stock Lapse financial
Form 144 regulatory
Equity Compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did the STERIS (STE) Form 144 report disclose?
Who is the reporting person on the Form 144 for STE?
How much value was reported for recent insider sales?
AI-generated analysis. How Rhea-AI works. Not financial advice.